Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series

J Allergy Clin Immunol. 2013 Oct;132(4):997-1000.e1-4. doi: 10.1016/j.jaci.2013.04.059. Epub 2013 Jun 20.

Authors

Nicolas Noel¹, Nizar Mahlaoui, Stéphane Blanche, Felipe Suarez, Hélène Coignard-Biehler, Isabelle Durieu, Philippe Godeberge, Harry Sokol, Emilie Catherinot, Sylvain Poiree, Hugo Chapdelaine, Bertrand Dunogue, Christine Bodemer, Marc Lecuit, Alain Fischer, Olivier Lortholary, Olivier Hermine

Affiliation

¹ Assistance Publique-Hôpitaux de Paris, CEREDIH, Centre de Référence Déficits Immunitaires Héréditaires, Hôpital Necker-Enfants Malades, Paris, France; Assistance Publique-Hôpitaux de Paris, Service de Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker Pasteur, Paris, France; Institut Imagine, Université Sorbonne Paris Cité, Paris, France.

PMID: 23791514
DOI: 10.1016/j.jaci.2013.04.059

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Child
Child, Preschool
Female
Granulomatous Disease, Chronic / drug therapy*
Granulomatous Disease, Chronic / immunology
Granulomatous Disease, Chronic / physiopathology
Humans
Immunosuppressive Agents* / administration & dosage
Immunosuppressive Agents* / adverse effects
Immunosuppressive Agents* / therapeutic use
Infant
Inflammation / drug therapy
Inflammation / immunology
Inflammation / physiopathology
Male
Retrospective Studies
Thalidomide* / administration & dosage
Thalidomide* / adverse effects
Thalidomide* / therapeutic use
Treatment Outcome

Substances

Immunosuppressive Agents
Thalidomide